Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, et al. Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials. BMC Gastroenterol 2024;24:121.
PMID: 38539103